£182.99

Stem Cells-Mediated Regeneration (Stem Cells - Laboratory and Clinical Research)

Price data last checked 137 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£183 today · usual range £0–£0 · best ever £165

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 594 days • 594 data points (No recent data available)

Historical
Generating forecast...
£231.45 £158.45 £174.38 £190.31 £206.23 £222.16 £238.09 11 June 2024 06 November 2024 03 April 2025 29 August 2025 25 January 2026

Price Distribution

Price distribution over 594 days • 5 price ranges

Days at Price
Current Price
199 days 288 days · current 23 days 34 days 50 days 0 72 144 216 288 £165-178 £178-192 £192-205 £205-218 £218-231 Days at Price

Price Analysis

Most common range: £178-192 (288 days, 48.5%)

Price range: £165 - £231

Price levels: 5 price ranges over 594 days

Description

Stem cells of varying potencies originating from the organ generating totipotent embryonic stem cells (ESCs) to terminally differented cells such as platelets formation, via pluripotent hematopoietic stem cells (HSCs), and their downstream multipotent mesenchymal stem cells (MSCs), have in general been well characterized. Thus majority of these different stem cell types and their differentiation progeny can be tracked for subjecting to further characterizations for clinical relevance and consequently needed biological modifications at the cellular and molecular levels, for patients clinical treatments. The very first section of this books contents deal with the above stated description. Such characterizations and research laboratory manipulations of the stem cells have led to their clinical grade applications and treatments with positive benefits, as described in the second section of this book. The clinical benefits as published by Nova Science Publishers herein as part of the contents are of tremendous significance and provide relief to the handicapped individuals, particularly for those who suffered lifes biological hazards. This naturally seeks R&D-mediated bench to bedside benefits and solutions for the genetically defective individuals. Bone marrow-derived stem cells with HSCs as their primary components are increasingly being cast the human eyes with pregnant females resorting cord blood banking as they peek to dwell into the future well being of their offspring(s) which could even benefit their own selves, should there be expectedly sufficient HLA matching. The third section of this book deals with such topics. The induced pluripotent stem cells (iPSCs) which were generated to overcome the ethical considerations of using ESCs were fraught with elaborate molecular and cellular biological engineering methods and the advent of derivation and usefulness of MSCs have since sidelined or relegated the iPSCs to a distant role. Nonetheless the hitherto served purpose of iPSCs is not discounted and yet unknown stumbling blocks of what seems to be a smooth going runway of MSCs may spring up in the clinical paths necessitated by the treatment along the future. In the fourth section of the book, it is to be kept in mind that uncontrolled proliferation of cells should be avoided at all costs. Whereas self-renewal of stem cells is generally expected to lead to a turnover, it need not be the case with regeneration processes. This will depend upon the genetic make up of the donor-derived and invasively injected stem cells plus accompanying biological reagent components, as well as also the recipients physical conditions. The fifth and last section of the book deals with conventional and alternative medicine topics applicable to carcinogenesis or such tendencies. Telomerase activity is a double edged sword. Therefore its homeostasis or equilibrium is to be maintained. Discriminatory apoptosis that is of beneficial nature affecting malignant cells but not the normal cells is necessary. Thus equation between apoptotic and telomerase activities even those of stem cells should be as hand in glove.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 December 2016
Listed Since
21 September 2016

Barcode

No barcode data available

Similar Products You Might Like

Telomeres and Telomerase in Cancer (Cancer Drug Discovery and Development)
96% match

Telomeres and Telomerase in Cancer (Cancer Drug Discovery and Development)

Humana

£144.62 22 Jan 2026
Telomeres and Telomerase in Cancer (Cancer Drug Discovery and Development)
96% match

Telomeres and Telomerase in Cancer (Cancer Drug Discovery and Development)

Humana

£51.14 28 Jan 2026
Telomerase, Aging and Disease (Volume 8) (Advances in Cell Aging and Gerontology, Volume 8)
95% match

Telomerase, Aging and Disease (Volume 8) (Advances in Cell Aging and Gerontology, Volume 8)

Elsevier

£95.00 15 Feb 2026
Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing
95% match

Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing

Springer

£105.15 10 Mar 2026
Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing
95% match

Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing

Springer

£148.11 10 Mar 2026
Telomerase Inhibition: Strategies and Protocols: 405 (Methods in Molecular Biology, 405)
95% match

Telomerase Inhibition: Strategies and Protocols: 405 (Methods in Molecular Biology, 405)

Humana

£36.17 08 Mar 2026
Cellular Aging: 14 (Modern Cell Biology)
95% match

Cellular Aging: 14 (Modern Cell Biology)

Wiley

£227.59 01 Feb 2026
Regulatory Networks in Stem Cells (Stem Cell Biology and Regenerative Medicine)
95% match

Regulatory Networks in Stem Cells (Stem Cell Biology and Regenerative Medicine)

Humana

£156.07 12 Jan 2026
Geriatric Medicine: An Evidence-Based Approach
95% match

Geriatric Medicine: An Evidence-Based Approach

Springer

£219.99 14 Feb 2026
Telomeres: Function, Shortening and Lengthening - Science Book
95% match

Telomeres: Function, Shortening and Lengthening - Science Book

£98.88 20 Apr 2026
Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury
94% match

Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury

Springer

£113.39 04 Apr 2026
The Role of DNA Damage and Repair in Cell Aging (Volume 4) (Advances in Cell Aging and Gerontology, Volume 4)
94% match

The Role of DNA Damage and Repair in Cell Aging (Volume 4) (Advances in Cell Aging and Gerontology, Volume 4)

Elsevier

£82.87 06 Mar 2026
Transcriptional and Translational Regulation of Stem Cells: 786 (Advances in Experimental Medicine and Biology, 786)
94% match

Transcriptional and Translational Regulation of Stem Cells: 786 (Advances in Experimental Medicine and Biology, 786)

Springer

£97.00 01 Apr 2026
Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury
94% match

Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury

Springer

£147.73 04 Apr 2026
Stem Cells and Cancer Stem Cells, Volume 7: Therapeutic Applications in Disease and Injury
94% match

Stem Cells and Cancer Stem Cells, Volume 7: Therapeutic Applications in Disease and Injury

Springer

£139.64 11 Jan 2026
Telomerases, Telomeres and Cancer (Molecular Biology Intelligence Unit)
94% match

Telomerases, Telomeres and Cancer (Molecular Biology Intelligence Unit)

Springer

£142.87 29 Jan 2026
Cell Biology and Translational Medicine, Volume 9: Stem Cell-Based Therapeutic Approaches in Disease: 1288 (Advances in Experimental Medicine and Biology, 1288)
94% match

Cell Biology and Translational Medicine, Volume 9: Stem Cell-Based Therapeutic Approaches in Disease: 1288 (Advances in Experimental Medicine and Biology, 1288)

Springer

£103.82 31 Jan 2026
Stem Cells in Regenerative Medicine: Carpe Diem - Carpe Vitam!
94% match

Stem Cells in Regenerative Medicine: Carpe Diem - Carpe Vitam!

£100.85 16 Apr 2026
Telomerase: Composition, Functions & Clinical Implications (DNA: Properties and Modifications, Functions and Interactions, Recombination and Applications)
94% match

Telomerase: Composition, Functions & Clinical Implications (DNA: Properties and Modifications, Functions and Interactions, Recombination and Applications)

£61.86 28 Feb 2026
Mesenchymal Stem Cell Therapy (Stem Cell Biology and Regenerative Medicine)
94% match

Mesenchymal Stem Cell Therapy (Stem Cell Biology and Regenerative Medicine)

Humana

£141.04 10 Jan 2026
Biology of Stem Cells and the Molecular Basis of the Stem State (Stem Cell Biology and Regenerative Medicine)
94% match

Biology of Stem Cells and the Molecular Basis of the Stem State (Stem Cell Biology and Regenerative Medicine)

Humana

£199.99 09 Jan 2026
Regenerative Medicine - from Protocol to Patient: 2. Stem Cell Science and Technology
94% match

Regenerative Medicine - from Protocol to Patient: 2. Stem Cell Science and Technology

Springer

£78.96 24 Feb 2026
Stem Cells and Aging: Methods and Protocols: 976 (Methods in Molecular Biology, 976)
94% match

Stem Cells and Aging: Methods and Protocols: 976 (Methods in Molecular Biology, 976)

Humana

£84.24 09 Mar 2026
Regulatory Networks in Stem Cells (Stem Cell Biology and Regenerative Medicine)
94% match

Regulatory Networks in Stem Cells (Stem Cell Biology and Regenerative Medicine)

Humana

£228.55 22 Jan 2026